Syra Health To Discuss First Quarter 2024 Financial Results
Conference call will be held on Thursday, May 9 at 9:00 AM ET
CARMEL, Ind., May 1, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it will report financial results for its first quarter 2024 ended March 31, 2024, on Thursday, May 9, 2024, before the market opens. The Company has scheduled a conference call that same day, May 9, 2024, at 9:00 a.m. ET, to review the results.
Interested parties can access the conference call via Internet webcast, which is available in the Investors section of the Company's website at https://ir.syrahealth.com/presentations/q1-2024-earnings-call.
Investors who would like to submit a question to be addressed on the call should email the question to [email protected].
A webcast replay will be available in the Investors section of the Company's website at https://ir.syrahealth.com/presentations/q1-2024-earnings-call.
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company addressing some of healthcare's most significant challenges in areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology solutions. Syra Health's products and services are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and government. For more information, please visit www.syrahealth.com.
For more information, please contact:
For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
[email protected]
For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-to-discuss-first-quarter-2024-financial-results-302132941.html
SOURCE Syra Health